📣 VC round data is live. Check it out!
- Public Comps
- i-SENS
i-SENS Valuation Multiples
Discover revenue and EBITDA valuation multiples for i-SENS and similar public comparables like Gooch & Housego, ECARX Group, Aeluma, Stemmer Imaging and more.
i-SENS Overview
About i-SENS
i-SENS Inc is a Korean company which is engaged in the manufacture and sale of biosensors. The product portfolio of the company includes blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others.
Founded
2000
HQ

Employees
N/A
Website
Financials (LTM)
EV
$439M
Valuation Multiples
Start free triali-SENS Financials
i-SENS reported last 12-month revenue of $217M and EBITDA of $17M.
In the same LTM period, i-SENS generated $89M in gross profit, $17M in EBITDA, and had net loss of ($1M).
i-SENS P&L
In the most recent fiscal year, i-SENS reported revenue of $216M and EBITDA of $17M.
i-SENS is unprofitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 8%, and net margin of (2%).
Financial data powered by Morningstar, Inc.
i-SENS Stock Performance
i-SENS has current market cap of $387M, and enterprise value of $439M.
i-SENS's stock price is $14.03.
i-SENS has an EPS (earnings per share) of $-0.12.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $439M | $387M | -0.4% | — | — | — | $-0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Triali-SENS Valuation Multiples
i-SENS trades at 2.0x EV/Revenue multiple, and 26.0x EV/EBITDA.
i-SENS Financial Valuation Multiples
As of May 10, 2026, i-SENS has market cap of $387M and EV of $439M.
i-SENS has a P/E ratio of (264.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified i-SENS Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


i-SENS Margins & Growth Rates
i-SENS grew revenue by 4% and EBITDA by 0% in the last fiscal year.
In the most recent fiscal year, i-SENS reported gross margin of 40%, EBITDA margin of 8%, and net margin of (2%).
i-SENS Margins
i-SENS Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
i-SENS Operational KPIs
i-SENS's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
i-SENS's Rule of X is 19% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
i-SENS Competitors
i-SENS competitors include Gooch & Housego, ECARX Group, Aeluma, Stemmer Imaging, LEM Holding, Beijing Piesat Informatio, Smart Eye, Seeing Machines, Sensortek and HUHUTECH.
Most i-SENS public comparables operate across Sensors & Monitoring and Industry 4.0.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.0x | 1.8x | 13.2x | 11.6x | |||
| 0.9x | 0.8x | (39.5x) | 680.8x | |||
| 86.4x | 76.5x | (2239.2x) | (182.4x) | |||
| 3.7x | — | 38.9x | — | |||
| 1.5x | 1.7x | 12.5x | 10.6x | |||
| 8.9x | 7.9x | (3.3x) | — | |||
| 6.7x | 5.3x | 542.5x | 29.9x | |||
| 5.1x | 3.9x | (63.9x) | 71.5x | |||
This data is available for Pro users. Sign up to see all i-SENS competitors and their valuation data. Start Free Trial | ||||||
i-SENS M&A Activity
i-SENS has acquired 2 companies to date.
Last acquisition by i-SENS was on May 17th 2023. i-SENS acquired AgaMatrix for $27M (EV/Revenue multiple of ).
Latest Acquisitions by i-SENS
| Description | AgaMatrix is a Salem, New Hampshire-headquartered developer of diabetes management devices. Its WaveSense technology powers blood glucose meters that correct for hematocrit, temperature, and strip variations, achieving high accuracy. The product line includes JAZZ and PRECIO meters, with Zero-Click data management software. Protected by over 160 patents, the FDA-cleared devices are distributed globally through partnerships with retailers and pharma companies. | CoaguSense is a manufacturer of point-of-care PT/INR monitoring systems for anticoagulation management. U.S.-based, its devices deliver lab-accurate results in seconds using fingerstick samples. Distributed to clinics and home users, the systems support warfarin therapy with data connectivity to EHRs. |
| HQ Country | ||
| HQ City | — | San Francisco, CA |
| Deal Date | 17 May 2023 | 1 Dec 2016 |
| Valuation | $27M | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all i-SENS acquisitions and their M&A valuation multiples. Start Free Trial | ||
i-SENS Investment Activity
i-SENS has invested in 1 company to date.
Latest investment by i-SENS was on November 6th 2023. i-SENS invested in Caremedi in their $20M Series B round (EV/Revenue multiple of ).
Latest Investments by i-SENS
| Description | — |
| HQ Country | |
| HQ City | — |
| Deal Date | 6 Nov 2023 |
| Round | Series B |
| Raised | $20M |
| Investors | AJU IB Investment Co; Atinum Investment; Company K Partners; i-SENS Inc; Korea Investment Partners |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all i-SENS investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout i-SENS
| When was i-SENS founded? | i-SENS was founded in 2000. |
| Where is i-SENS headquartered? | i-SENS is headquartered in South Korea. |
| Is i-SENS publicly listed? | Yes, i-SENS is a public company listed on Korea Exchange. |
| What is the stock symbol of i-SENS? | i-SENS trades under 099190 ticker. |
| When did i-SENS go public? | i-SENS went public in 2013. |
| Who are competitors of i-SENS? | i-SENS main competitors include Gooch & Housego, ECARX Group, Aeluma, Stemmer Imaging, LEM Holding, Beijing Piesat Informatio, Smart Eye, Seeing Machines, Sensortek, HUHUTECH. |
| What is the current market cap of i-SENS? | i-SENS's current market cap is $387M. |
| What is the current revenue of i-SENS? | i-SENS's last 12 months revenue is $217M. |
| What is the current revenue growth of i-SENS? | i-SENS revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of i-SENS? | Current revenue multiple of i-SENS is 2.0x. |
| Is i-SENS profitable? | Yes, i-SENS is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of i-SENS? | i-SENS's last 12 months EBITDA is $17M. |
| What is i-SENS's EBITDA margin? | i-SENS's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of i-SENS? | Current EBITDA multiple of i-SENS is 26.0x. |
| What is the current FCF of i-SENS? | i-SENS's last 12 months FCF is ($3M). |
| What is i-SENS's FCF margin? | i-SENS's last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of i-SENS? | Current FCF multiple of i-SENS is (141.1x). |
| How many companies i-SENS has acquired to date? | As of May 2026, i-SENS has acquired 2 companies. |
| What was the largest acquisition by i-SENS? | $27M acquisition of AgaMatrix on 17th May 2023 was the largest M&A i-SENS has done to date. |
| What companies i-SENS acquired? | i-SENS acquired AgaMatrix and CoaguSense. |
| In how many companies i-SENS has invested to date? | As of May 2026, i-SENS has invested in 1 company. |
| What was the last i-SENS investment? | On 6th November 2023 i-SENS invested in Caremedi, participating in a $20M Series B round, alongside AJU IB Investment Co, Atinum Investment, Company K Partners, i-SENS Inc, and Korea Investment Partners. |
| In what companies i-SENS invested in? | i-SENS invested in Caremedi. |
See public comps similar to i-SENS
Lists including i-SENS
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

